FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029828620> ?p ?o ?g. }

• W2029828620 endingPage "776" @default.
• W2029828620 startingPage "770" @default.
• W2029828620 abstract "To evaluate the safety and immunogenicity of a prototype quadrivalent inactivated influenza vaccine (QIV) containing two influenza B strains, one of each lineage, compared with licensed trivalent inactivated influenza vaccines (TIVs) containing either a Victoria B-lineage strain (2009–2010 TIV) or a Yamagata B-lineage strain (2008–2009 TIV). Healthy adults ≥18 years of age were eligible to participate in this phase II, open-label, randomized, controlled, multicenter study conducted in the US. Participants received a single dose of 2009–2010 TIV, 2008–2009 TIV, or QIV. Sera were collected before and 21 days after vaccine administration to test for hemagglutination inhibition (HAI) antibodies to each of the four influenza strains. Immunogenicity endpoints included geometric mean HAI antibody titers (GMTs) and rates of seroprotection (titer ≥1:40) and seroconversion (4-fold rise pre- to post-vaccination). Safety endpoints included frequency of solicited injection-site and systemic reactions occurring within 3 days of vaccination, and unsolicited non-serious adverse events (AEs) and serious AEs (SAEs) within 21 days of vaccination. One hundred and ninety participants were enrolled to each vaccine group. QIV induced GMTs to each A and B strain that were noninferior to those induced by the 2009–2010 and 2008–2009 TIVs (i.e., lower limit of the two-sided 95% confidence interval of the ratio of GMTQIV/GMTTIV > 0.66 for each strain). Rates of seroprotection and seroconversion were similar in all groups. Incidence and severity of solicited injection-site and systemic reactions, AEs, and SAEs were similar among groups. QIV, containing two B strains (one from each B lineage), was as safe and immunogenic as licensed TIV. QIV has the potential to be a useful alternative to TIV and offer protection against both B lineages." @default.
• W2029828620 created "2016-06-24" @default.
• W2029828620 creator A5017945343 @default.
• W2029828620 creator A5028844100 @default.
• W2029828620 creator A5058227838 @default.
• W2029828620 creator A5084392936 @default.
• W2029828620 creator A5085133920 @default.
• W2029828620 creator A5087981002 @default.
• W2029828620 date "2013-01-01" @default.
• W2029828620 modified "2023-09-23" @default.
• W2029828620 title "Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults" @default.
• W2029828620 cites W1553686131 @default.
• W2029828620 cites W1978340974 @default.
• W2029828620 cites W1991187025 @default.
• W2029828620 cites W1998553355 @default.
• W2029828620 cites W2014289441 @default.
• W2029828620 cites W2015260696 @default.
• W2029828620 cites W2018063580 @default.
• W2029828620 cites W2075196857 @default.
• W2029828620 cites W2089150162 @default.
• W2029828620 cites W2089290551 @default.
• W2029828620 cites W2114497241 @default.
• W2029828620 cites W2124834066 @default.
• W2029828620 cites W2139841187 @default.
• W2029828620 cites W2164949714 @default.
• W2029828620 cites W2167279670 @default.
• W2029828620 cites W2171085746 @default.
• W2029828620 doi "https://doi.org/10.1016/j.vaccine.2012.11.074" @default.
• W2029828620 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23228813" @default.
• W2029828620 hasPublicationYear "2013" @default.
• W2029828620 type Work @default.
• W2029828620 sameAs 2029828620 @default.
• W2029828620 citedByCount "98" @default.
• W2029828620 countsByYear W20298286202013 @default.
• W2029828620 countsByYear W20298286202014 @default.
• W2029828620 countsByYear W20298286202015 @default.
• W2029828620 countsByYear W20298286202016 @default.
• W2029828620 countsByYear W20298286202017 @default.
• W2029828620 countsByYear W20298286202018 @default.
• W2029828620 countsByYear W20298286202019 @default.
• W2029828620 countsByYear W20298286202020 @default.
• W2029828620 countsByYear W20298286202021 @default.
• W2029828620 countsByYear W20298286202022 @default.
• W2029828620 countsByYear W20298286202023 @default.
• W2029828620 crossrefType "journal-article" @default.
• W2029828620 hasAuthorship W2029828620A5017945343 @default.
• W2029828620 hasAuthorship W2029828620A5028844100 @default.
• W2029828620 hasAuthorship W2029828620A5058227838 @default.
• W2029828620 hasAuthorship W2029828620A5084392936 @default.
• W2029828620 hasAuthorship W2029828620A5085133920 @default.
• W2029828620 hasAuthorship W2029828620A5087981002 @default.
• W2029828620 hasConcept C126322002 @default.
• W2029828620 hasConcept C133239900 @default.
• W2029828620 hasConcept C159047783 @default.
• W2029828620 hasConcept C159654299 @default.
• W2029828620 hasConcept C182072434 @default.
• W2029828620 hasConcept C197934379 @default.
• W2029828620 hasConcept C203014093 @default.
• W2029828620 hasConcept C22070199 @default.
• W2029828620 hasConcept C2522874641 @default.
• W2029828620 hasConcept C2776872762 @default.
• W2029828620 hasConcept C2777451964 @default.
• W2029828620 hasConcept C2780689484 @default.
• W2029828620 hasConcept C2780868878 @default.
• W2029828620 hasConcept C2909469553 @default.
• W2029828620 hasConcept C32611913 @default.
• W2029828620 hasConcept C44249647 @default.
• W2029828620 hasConcept C71924100 @default.
• W2029828620 hasConceptScore W2029828620C126322002 @default.
• W2029828620 hasConceptScore W2029828620C133239900 @default.
• W2029828620 hasConceptScore W2029828620C159047783 @default.
• W2029828620 hasConceptScore W2029828620C159654299 @default.
• W2029828620 hasConceptScore W2029828620C182072434 @default.
• W2029828620 hasConceptScore W2029828620C197934379 @default.
• W2029828620 hasConceptScore W2029828620C203014093 @default.
• W2029828620 hasConceptScore W2029828620C22070199 @default.
• W2029828620 hasConceptScore W2029828620C2522874641 @default.
• W2029828620 hasConceptScore W2029828620C2776872762 @default.
• W2029828620 hasConceptScore W2029828620C2777451964 @default.
• W2029828620 hasConceptScore W2029828620C2780689484 @default.
• W2029828620 hasConceptScore W2029828620C2780868878 @default.
• W2029828620 hasConceptScore W2029828620C2909469553 @default.
• W2029828620 hasConceptScore W2029828620C32611913 @default.
• W2029828620 hasConceptScore W2029828620C44249647 @default.
• W2029828620 hasConceptScore W2029828620C71924100 @default.
• W2029828620 hasIssue "5" @default.
• W2029828620 hasLocation W20298286201 @default.
• W2029828620 hasLocation W20298286202 @default.
• W2029828620 hasOpenAccess W2029828620 @default.
• W2029828620 hasPrimaryLocation W20298286201 @default.
• W2029828620 hasRelatedWork W1121313025 @default.
• W2029828620 hasRelatedWork W1531392509 @default.
• W2029828620 hasRelatedWork W1975211391 @default.
• W2029828620 hasRelatedWork W2027457674 @default.
• W2029828620 hasRelatedWork W2038899530 @default.
• W2029828620 hasRelatedWork W2044638330 @default.
• W2029828620 hasRelatedWork W2110382882 @default.
• W2029828620 hasRelatedWork W2358831769 @default.

• next